Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 21, 2021
Comparison of water vapor thermal therapy and prostate artery embolization for fragile patients with indwelling urinary catheters: Preliminary results from a multi-institutional studyM Baboudjian, C Alegorides, M Fourmarier, et al.
Frontiers in Plant Science|July 9, 2021
Activation of <i>PsMYB10.2</i> Transcription Causes Anthocyanin Accumulation in Flesh of the Red-Fleshed Mutant of 'Sanyueli' (<i>Prunus salicina</i> Lindl.)Zhi-Zhen Fang, Kui Lin-Wang, Dan-Rong Zhou, et al.
International Urology and Nephrology|September 4, 2020
Immediate preoperative renal artery embolization in the resection of complex renal tumors (UroCCR-48 Reinbol study)C Alegorides, P Bigot, J Hardwigsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic studyStephan A Veltkamp, Robert S Jansen, Sophie Callies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trialN Mounier, P Brice, S Bologna, et al.
Brain : a Journal of Neurology|November 18, 2005
Contralateral hemimicrencephaly and clinical-pathological correlations in children with hemimegalencephalyNoriko Salamon, Marissa Andres, Dennis J Chute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignanciesPaula M Fracasso, Lori J Goldstein, Dinesh P de Alwis, et al.
Epilepsia|January 30, 2009
Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experienceJason T Lerner, Noriko Salamon, Jason S Hauptman, et al.
Breast Cancer Research and Treatment|August 14, 2020
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1Hope S Rugo, Veronique Dieras, Javier Cortes, et al.
Blood|July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 studyR-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Pageof 17